The Food and Drug Administration is prioritizing and reviewing applications to expand production activities from baby formula suppliers and releasing guidance to import formula that is currently not on the U.S. market, senior White House officials said.
“We took another important step with the FDA releasing guidance under which major formula manufacturers can ask to safely import formula that is not currently being produced for the U.S. market,” a senior administration official said. “Companies will need to apply with the FDA, and the FDA is prepared to review applications quickly and respond to them rapidly.”
The FDA will be prioritizing applications from suppliers that will get the “most formula to your shelves as quickly as possible,” the official added.
Formula imports could come from countries such as Ireland, Chile, and the Netherlands, among others, though officials stressed that all imports will be rigorously tested to ensure they meet safety standards.
“We understand how stressful it is for parents trying to feed their children,” a senior administration official said.
Earlier Monday, baby formula maker Abbott announced it had reached a deal with federal regulators to reopen a production facility in Michigan.